| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | ACETAMINOPHEN | 3 |
| 2 | INFLIXIMAB | 3 |
| 3 | PREDNISONE | 3 |
| 4 | QUETIAPINE | 3 |
| 5 | SERTRALINE HYDROCHLORIDE | 3 |
| 6 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 7 | ALENDRONATE SODIUM | 2 |
| 8 | ARIPIPRAZOLE | 2 |
| 9 | ARIPIPRAZOLE ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE | 1 | 0.0013 |
| 1 | CUPRIC CHLORIDE | 1 | 0.0013 |
| 2 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 3 | HYDROCORTISONE BUTYRATE | 1 | 0.0005 |
| 4 | CODEINE SULFATE | 1 | 0.0003 |
| 5 | ZIPRASIDONE | 1 | 0.0003 |
| 6 | ARIPIPRAZOLE LAUROXIL | 1 | 0.0002 |
| 7 | IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) | 1 | 0.0002 |
| 8 | DIMENHYDRINATE | 2 | 0.0002 |
| 9 | TASIMELTEON | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 7 |
| 1 | Corticosteroid [EPC] | 4 |
| 2 | Atypical Antipsychotic [EPC] | 3 |
| 3 | Benzodiazepine [EPC] | 3 |
| 4 | Insulin Analog [EPC] | 3 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| 6 | Vitamin C [EPC] | 3 |
| 7 | Azole Antifungal [EPC] | 2 |
| 8 | Expectorant [EPC] | 2 |
| 9 | Hepatitis C Virus NS5A Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 1 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 2 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 4 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 5 | Hepatitis C Virus NS5A Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Copper-containing Intrauterine Device [EPC] | 1 | 0.0000 |